BioCentury
ARTICLE | Clinical News

Duragesic fentanyl regulatory update

July 18, 2005 7:00 AM UTC

Johnson & Johnson (JNJ), New Brunswick, N.J. Product: Duragesic fentanyl Business: Neurology JNJ issued a "Dear Healthcare Professional" letter with revisions to the boxed warning/warnings, contraind...